2C-G-5:
900,
901,
902,
903
Shulgin, AT. Basic Pharmacology and Effects In Hallucinogens. A Forensic Drug Handbook; Laing, R; Siegel, JA, Eds., Academic Press, London, 24 Apr 2003; pp 67–137. 6.3 MB.
Jacob, P; Shulgin, AT. Structure-activity relationships of the classic hallucinogens and their analogs In Hallucinogens: An update. NIDA Research Monograph 146; Lin, GC; Glennon, RA, Eds., U.S. Department of Health and Human Services, National Institute of Health, U.S. Government Printing Office, Washington, DC, 1 Jan 1994; pp 74–91. 51 kB.
Clare, BW. The frontier orbital phase angles: Novel QSAR descriptors for benzene derivatives, applied to phenylalkylamine hallucinogens J. Med. Chem., 24 Sep 1998, 41 (20), 3845–3856. 239 kB. https://doi.org/10.1021/jm980144c #47
4-MeO-α-PBP · 4′-Methoxy-α-(pyrrolidin-1-yl)butanophenone
ED-pyr-A · α-Methyl-3,4-ethylenedioxyphenethylpyrrolidine
4′-Hydroxy-α-(pyrrolidin-1-yl)valerophenone · O-2418
4-Me-MPH · 4-Methylmethylphenidate
3-MeO-2′-Oxo-PCE · MXE · Methoxetamine
3-Methoxy-PPPO · 3′-Methoxy-α-(piperidin-1-yl)propanophenone
N-Cyclopentyl-3-methoxycathinone